International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.10058151
Original Article
Role of Ai in the Diagnosis and Management of Parkinsonism
 ,
Published
Oct. 31, 2023
Abstract

Parkinson's Disease (PD) is an age-related progressive neurodegenerative disease that poses significant challenges for both patients and healthcare providers. One of the crucial challenges in PD diagnosis and management is the absence of reliable diagnostic biomarkers and variability in PD symptoms, leading to potential misdiagnoses. Artificial Intelligence (AI) solutions and quantum computing techniques can be utilized to enhance PD diagnosis, monitoring, and treatment. Several AI-based tools and systems have been developed that facilitate early diagnosis, continuous monitoring, data integration, and medication optimization. Quantum computing algorithms can further be developed to analyze medical data and make predictions regarding PD presence and progression. The accurate diagnosis of Parkinson's disease can be achieved through AI, and there is need for a strong collaboration between Artificial Intelligence (AI) and healthcare systems that can adapt to evolving needs. This will lead to a significant contribution to advancing AI in healthcare and improving patient well-being.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
962 Views
344 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved